The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (10), p.1228-1239 [Peer Reviewed Journal]2010 Blackwell Publishing Ltd ;2015 INIST-CNRS ;2010 Blackwell Publishing Ltd. ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/j.1365-2036.2010.04466.x ;PMID: 20955442
Full text available